These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21281469)

  • 1. Effects of EpCAM overexpression on human breast cancer cell lines.
    Gostner JM; Fong D; Wrulich OA; Lehne F; Zitt M; Hermann M; Krobitsch S; Martowicz A; Gastl G; Spizzo G
    BMC Cancer; 2011 Jan; 11():45. PubMed ID: 21281469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
    Martowicz A; Spizzo G; Gastl G; Untergasser G
    BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
    Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
    Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.
    Sankpal NV; Fleming TP; Gillanders WE
    Mol Cancer Res; 2013 Apr; 11(4):418-26. PubMed ID: 23378578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.
    Soysal SD; Muenst S; Barbie T; Fleming T; Gao F; Spizzo G; Oertli D; Viehl CT; Obermann EC; Gillanders WE
    Br J Cancer; 2013 Apr; 108(7):1480-7. PubMed ID: 23519058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
    Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
    Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells.
    Henrich CJ; Budhu A; Yu Z; Evans JR; Goncharova EI; Ransom TT; Wang XW; McMahon JB
    Chem Biol Drug Des; 2013 Aug; 82(2):131-9. PubMed ID: 23879724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.
    Sankpal NV; Mayfield JD; Willman MW; Fleming TP; Gillanders WE
    Breast Cancer Res; 2011; 13(6):R124. PubMed ID: 22132731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.
    Martowicz A; Rainer J; Lelong J; Spizzo G; Gastl G; Untergasser G
    Mol Cancer; 2013 Jun; 12():56. PubMed ID: 23758908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
    Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
    J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of EpCAM and Wnt/ β-catenin in human colon cancer.
    Zhou FQ; Qi YM; Xu H; Wang QY; Gao XS; Guo HG
    Genet Mol Res; 2015 May; 14(2):4485-94. PubMed ID: 25966221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.
    Sankpal NV; Willman MW; Fleming TP; Mayfield JD; Gillanders WE
    Cancer Res; 2009 Feb; 69(3):753-7. PubMed ID: 19141643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-7 regulates EpCAM-mediated functions in tumor progression.
    Nübel T; Preobraschenski J; Tuncay H; Weiss T; Kuhn S; Ladwein M; Langbein L; Zöller M
    Mol Cancer Res; 2009 Mar; 7(3):285-99. PubMed ID: 19276185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
    Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
    Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
    Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
    PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of EpCAM enhances the chemosensitivity of breast cancer cells to 5-fluorouracil by downregulating the antiapoptotic factor Bcl-2.
    Gao J; Yan Q; Liu S; Yang X
    PLoS One; 2014; 9(7):e102590. PubMed ID: 25019346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.